TRIHYDRATE DE METAHENSULFONATE DE (1S,2S)-1-(4-HYDROXYPHENYL) -2-(4-HYDROXY-4-PHENYLPIPERIDINE-1-YL)-1-PROPANOL ET COMPOSITION PHARMACEUTIQUE LE CONTENANT
L'INVENTION CONCERNE LE TRIHYDRATE DU MESYLATE DE (1S, 2S)- 1- (4-HYDROXYPHENYL) -2-(4-HYDROXY-4-PHENYLPIPERIDINE-1-YL)-1-PROPANOL . ELLE CONCERNE EGALEMENT DES COMPOSITIONS PHARMACEUTIQUES CONTENANT CE COMPOSE. APPLICATION : METHODES D'UTILISATION DE CE COMPOSE POUR LE TRAITEMENT D'A...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | L'INVENTION CONCERNE LE TRIHYDRATE DU MESYLATE DE (1S, 2S)- 1- (4-HYDROXYPHENYL) -2-(4-HYDROXY-4-PHENYLPIPERIDINE-1-YL)-1-PROPANOL . ELLE CONCERNE EGALEMENT DES COMPOSITIONS PHARMACEUTIQUES CONTENANT CE COMPOSE. APPLICATION : METHODES D'UTILISATION DE CE COMPOSE POUR LE TRAITEMENT D'AFFECTIONS DU SNC.
PCT No. PCT/IB96/00592 Sec. 371 Date May 7, 1998 Sec. 102(e) Date May 7, 1998 PCT Filed Jun. 20, 1996 PCT Pub. No. WO97/07098 PCT Pub. Date Feb. 27, 1997The invention relates to the trihydrate of the mesylate salt of (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol, pharmaceutical compositions containing said compound and methods of treating disorders of the central nervous system by administering said compound. |
---|